IMNM
Immunome Inc

2,227
Mkt Cap
$2.48B
Volume
386.00
52W High
$27.65
52W Low
$5.15
PE Ratio
-7.59
IMNM Fundamentals
Price
$22.44
Prev Close
$23.41
Open
$24.20
50D MA
$22.24
Beta
1.39
Avg. Volume
2.12M
EPS (Annual)
-$5.00
P/B
7.80
Rev/Employee
$76,618.64
$410.28
Loading...
Loading...
News
all
press releases
Principal Financial Group Inc. Buys 762,147 Shares of Immunome, Inc. $IMNM
Principal Financial Group Inc. lifted its stake in shares of Immunome, Inc. (NASDAQ:IMNM - Free Report) by 222.3% during the third quarter, according to its most recent disclosure with the Securities...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Candriam S.C.A. Buys 541,441 Shares of Immunome, Inc. $IMNM
Candriam S.C.A. boosted its stake in Immunome, Inc. (NASDAQ:IMNM - Free Report) by 170.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned...
MarketBeat·2d ago
News Placeholder
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Immunome, Inc. (the Company) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, announced today that on February 2, 2026, the...
Business Wire·8d ago
News Placeholder
Immunome (NASDAQ:IMNM) Hits New 1-Year High - What's Next?
Immunome (NASDAQ:IMNM) Reaches New 1-Year High - Here's Why...
MarketBeat·10d ago
News Placeholder
Immunome, Inc. (NASDAQ:IMNM) Short Interest Down 12.6% in January
Immunome, Inc. (NASDAQ:IMNM - Get Free Report) saw a significant decrease in short interest in the month of January. As of January 15th, there was short interest totaling 15,314,650 shares, a...
MarketBeat·10d ago
News Placeholder
Nan Fung Trinity HK Ltd. Has $6.93 Million Position in Immunome, Inc. $IMNM
Nan Fung Trinity HK Ltd. lifted its position in Immunome, Inc. (NASDAQ:IMNM - Free Report) by 7.9% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund...
MarketBeat·13d ago
News Placeholder
Immunome, Inc. (NASDAQ:IMNM) Receives Consensus Recommendation of "Moderate Buy" from Analysts
Immunome, Inc. (NASDAQ:IMNM - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the eleven ratings firms that are currently covering the company, MarketBeat.com reports...
MarketBeat·14d ago
News Placeholder
Immunome (NASDAQ:IMNM) Hits New 12-Month High - What's Next?
Immunome (NASDAQ:IMNM) Reaches New 1-Year High - Here's What Happened...
MarketBeat·22d ago
News Placeholder
Immunome, Inc. $IMNM Holdings Boosted by Nisa Investment Advisors LLC
Nisa Investment Advisors LLC raised its stake in Immunome, Inc. (NASDAQ:IMNM - Free Report) by 3,513.0% in the third quarter, according to the company in its most recent disclosure with the...
MarketBeat·28d ago
News Placeholder
Immunome (NASDAQ:IMNM) Trading 8.1% Higher - Here's Why
Immunome (NASDAQ:IMNM) Trading Up 8.1% - Here's What Happened...
MarketBeat·29d ago
<
1
2
...
>

Latest IMNM News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.